A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study of TT223 in Patients With Type 2 Diabetes Treated With Metformin and/or TZD

Trial Profile

A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study of TT223 in Patients With Type 2 Diabetes Treated With Metformin and/or TZD

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Jun 2013

At a glance

  • Drugs TT 223 (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 30 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 25 Jan 2010 Results presented in a Transition Therapeutics media release.
    • 18 Feb 2009 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top